Literature DB >> 10465649

EBNA-1 sequences in endemic and sporadic Burkitt's lymphoma.

K Bhatia, I Magrath.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10465649      PMCID： PMC112804     

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


× No keyword cloud information.
  10 in total

1.  Sequence variations in EBNA-1 may dictate restriction of tissue distribution of Epstein-Barr virus in normal and tumour cells.

Authors:  M I Gutiérrez; A Raj; G Spangler; A Sharma; A Hussain; J G Judde; S W Tsao; P W Yuen; I Joab; I T Magrath; K Bhatia
Journal:  J Gen Virol       Date:  1997-07       Impact factor: 3.891

2.  Evolutionary dynamics of genetic variation in Epstein-Barr virus isolates of diverse geographical origins: evidence for immune pressure-independent genetic drift.

Authors:  R Khanna; R W Slade; L Poulsen; D J Moss; S R Burrows; J Nicholls; J M Burrows
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

3.  Variation in the sequence of Epstein Barr virus nuclear antigen 1 in normal peripheral blood lymphocytes and in Burkitt's lymphomas.

Authors:  K Bhatia; A Raj; M I Guitierrez; J G Judde; G Spangler; H Venkatesh; I T Magrath
Journal:  Oncogene       Date:  1996-07-04       Impact factor: 9.867

4.  Diversity of naturally occurring Epstein-Barr virus revealed by nucleotide sequence polymorphism in hypervariable domains in the BamHI K and N subgenomic regions.

Authors:  D Triantos; A W Boulter; J C Leao; L Di Alberti; S R Porter; C M Scully; W Birnbaum; N W Johnson; C G Teo
Journal:  J Gen Virol       Date:  1998-11       Impact factor: 3.891

5.  EBV strain variation: geographical distribution and relation to disease state.

Authors:  M Abdel-Hamid; J J Chen; N Constantine; M Massoud; N Raab-Traub
Journal:  Virology       Date:  1992-09       Impact factor: 3.616

6.  Epstein-barr virus nuclear antigen 1 sequences in endemic and sporadic Burkitt's lymphoma reflect virus strains prevalent in different geographic areas.

Authors:  G Habeshaw; Q Y Yao; A I Bell; D Morton; A B Rickinson
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

7.  Epstein-Barr virus-associated nuclear antigen-1 carboxy-terminal gene sequences in Japanese and American patients with gastric carcinoma.

Authors:  Y Y Chen; K L Chang; W G Chen; D Shibata; K Hayashi; L M Weiss
Journal:  Lab Invest       Date:  1998-07       Impact factor: 5.662

8.  Epstein-Barr virus in nasal lymphomas contains multiple ongoing mutations in the EBNA-1 gene.

Authors:  M I Gutiérrez; G Spangler; D Kingma; M Raffeld; I Guerrero; O Misad; E S Jaffe; I T Magrath; K Bhatia
Journal:  Blood       Date:  1998-07-15       Impact factor: 22.113

9.  Alterations in the structure of the EBV nuclear antigen, EBNA1, in epithelial cell tumours.

Authors:  D K Snudden; P R Smith; D Lai; M H Ng; B E Griffin
Journal:  Oncogene       Date:  1995-04-20       Impact factor: 9.867

10.  T cell responses and virus evolution: loss of HLA A11-restricted CTL epitopes in Epstein-Barr virus isolates from highly A11-positive populations by selective mutation of anchor residues.

Authors:  P O de Campos-Lima; V Levitsky; J Brooks; S P Lee; L F Hu; A B Rickinson; M G Masucci
Journal:  J Exp Med       Date:  1994-04-01       Impact factor: 14.307
  10 in total
  1 in total

1.  Carcinoma-risk variant of EBNA1 deregulates Epstein-Barr Virus episomal latency.

Authors:  Jayaraju Dheekollu; Kimberly Malecka; Andreas Wiedmer; Henri-Jacques Delecluse; Alan K S Chiang; Dario C Altieri; Troy E Messick; Paul M Lieberman
Journal:  Oncotarget       Date:  2017-01-31
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.